Utility of 18F-FDG uptake in predicting major pathological response to neoadjuvant immunotherapy in patients with resectable non‑small cell lung cancer

Xiaowei Chen,Guangyu Bai,Ruochuan Zang,Peng Song,Fenglong Bie,Qilin Huai,Yuan Li,Yang Liu,Bolun Zhou,Yifan Bie,Zhenlin Yang,Shugeng Gao

Translational oncology（2023）

引用 0|浏览4

暂无评分

摘要

•18F-FDG uptake is closely associated with tumor response to ICI treatment.•18F-FDG uptake can predict MPR to neoadjuvant ICI treatment in resectable NSCLC.•18F-FDG PET-CT is superior to inflammatory biomarkers in MPR evaluation.•18F-FDG PET-CT has advantage over TMB and PD-L1 TPS in predicting MPR.

查看译文

关键词

Non-small cell lung cancer, neoadjuvant immunotherapy, 18F-FDG PET-CT, maximum standardized uptake value, major pathological response

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要